These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 22285095

  • 1. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
    Griesser H, Skonietzki S, Fischer T, Fielder K, Suesskind M.
    Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095
    [Abstract] [Full Text] [Related]

  • 2. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J.
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [Abstract] [Full Text] [Related]

  • 3. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA, Reape KZ, Wininger S, Hait H.
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [Abstract] [Full Text] [Related]

  • 7. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
    Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I.
    Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
    [Abstract] [Full Text] [Related]

  • 8. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F.
    Maturitas; 2005 Feb 14; 50(2):98-104. PubMed ID: 15653006
    [Abstract] [Full Text] [Related]

  • 9. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
    Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE.
    Menopause; 2018 Jan 14; 25(1):21-28. PubMed ID: 28763401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E.
    Menopause; 2004 Jan 14; 11(1):49-56. PubMed ID: 14716182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
    Jonasson AF, Edwall L, Uvnäs-Moberg K.
    Menopause Int; 2011 Dec 14; 17(4):120-5. PubMed ID: 22120944
    [Abstract] [Full Text] [Related]

  • 16. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R, Hesla K, Sørdal T, Aase KH, Lilleeidet O, Wickstrøm E.
    Acta Obstet Gynecol Scand; 2000 Apr 14; 79(4):293-7. PubMed ID: 10746845
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D, Palacios S, Nappi RE, Mueck AO.
    Maturitas; 2014 Jun 14; 78(2):91-8. PubMed ID: 24679891
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
    Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G.
    BJOG; 2005 Feb 14; 112(2):234-40. PubMed ID: 15663590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.